FDA Approval Activities for this Drug…

Raplon (rapacuronium bromide) Injection,100 mg/5 mL, 200 mg/10 mL Vial. Organon, Inc NDA 20-984 8/18/99 9/24/99 9/24/99 7/2/01 Raplon Indications: Indicated for outpatients and inpatients as an adjunct to general anesthesia to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgical procedures.

For the latest approval information, please locate this drug using this index.